# Replimune Group, Inc.: Form 8-K, filed Nov 5, 2020

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2020-11-05
- Accepted by EDGAR: Nov 5, 2020, 08:19 ET
- Period: 2020-11-05
- Accession: 0001104659-20-121601
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465920121601/tm2034385d3_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465920121601/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465920121601/tm2034385d3_8k.htm

Filed Nov 5, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-121601. Last ingested by Listed: Nov 10, 2026, 04:35 ET. No prices; not investment advice.